-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-08-21
Saito and colleagues established a streamlined three-dimensional culture strategy for generating human induced pluripotent stem cell-derived intestinal organoids with sustained expansion, differentiation capacity, and cryopreservation potential. The resulting epithelial cells displayed enterocyte-associated cytochrome P450 and transporter activities, supporting a more human-relevant in vitro platform for intestinal absorption and drug-metabolism studies.
-
HA-LNP PTEN mRNA for Transdermal Melanoma Therapy
2026-08-20
Kim and colleagues developed a hyaluronate-conjugated lipid nanoparticle that delivers PTEN mRNA through the skin and targets CD44-expressing melanoma cells. The study links localized PTEN restoration with reduced melanoma viability, immunogenic cell death, tumor growth inhibition, and immune activation while identifying important translational questions about formulation, biodistribution, and model scope.
-
KU-55933: ATM Kinase Inhibitor Workflow Guide
2026-08-20
KU-55933 is a selective ATM kinase inhibitor for mapping DNA damage response, Akt signaling, cell-cycle behavior, and metabolic stress. This workflow combines mechanism-first controls with practical solubility, dosing, and troubleshooting guidance, while using a mitochondrial stress study to design sharper follow-up experiments.
-
SARS-CoV-2 N Protein Sequesters GADD34 mRNA
2026-08-19
The reference study identifies an atypical stress-granule mechanism by which SARS-CoV-2 nucleocapsid protein recruits GADD34 mRNA into N+/G3BP1+ foci. This reduces GADD34-dependent IRF3 nuclear translocation and weakens interferon production, providing a mechanistic explanation for part of SARS-CoV-2 innate immune evasion.
-
Carbohydrate-Decorated Nanoparticles Target Macrophages
2026-08-19
Chen and colleagues developed biodegradable nanoparticles decorated with mannose, galactose, dextran, or mixed carbohydrate ligands to improve gene delivery to macrophages. Their results connect carbohydrate-dependent uptake with mRNA transfection, while also showing that nanoparticle composition can improve delivery without detectable cytotoxicity under the tested conditions.
-
Podophyllotoxin: Mechanism and Cancer Research
2026-08-18
Podophyllotoxin is a microtubule-directed natural product used to study mitotic disruption, cell-cycle arrest, and apoptosis. The related diterpene JXE-23 provides HCC autophagy evidence, but it is chemically distinct and must not be presented as direct Podophyllotoxin evidence.
-
PCNA–POLD1 Endoreplication in Myocardial Hypertrophy
2026-08-18
The reference study identifies cardiomyocyte PCNA–POLD1–dependent DNA synthesis as a causal driver of pathological hypertrophic growth rather than a passive marker of remodeling. Its genetic, biochemical, and translational experiments show that increasing p21 or directly disrupting this pathway limits cardiomyocyte endoreplication and improves diastolic function in a preclinical hypertrophic cardiomyopathy model.
-
Sulfisomidine in Pertussis: Evidence and Study Design
2026-08-17
The 1956 report on sulfisomidine in pertussis is notable for combining oral drug therapy with pertussis serum while systematically tracking blood and urine concentrations in a predominantly infant cohort. Its findings support historical pharmacokinetic feasibility and highlight hydration-related safety monitoring, but the uncontrolled design cannot establish comparative efficacy.
-
Cl-Amidine: PAD4 Inhibition for Translational Research
2026-08-17
Cl-Amidine is a protein arginine deiminase 4 inhibitor supplied as the Cl-Amidine trifluoroacetate salt. Product information reports a 5.9 μM in-vitro PAD4 IC50 and protective activity in a septic shock murine model, while clinical efficacy remains unestablished.
-
Dorsomorphin 2HCl: AMPK Inhibitor Guide
2026-08-16
Dorsomorphin 2HCl is a preclinical AMPK inhibitor and BMP signaling pathway inhibitor used to dissect metabolic, osteogenic, and iron-regulatory biology. Its dual pathway activity makes it useful for mechanistic studies, but it requires careful interpretation, vehicle control, and orthogonal validation.
-
Saquinavir: HIV Protease Inhibitor Research Guide
2026-08-15
Saquinavir is an HIV protease inhibitor that blocks proteolytic maturation of HIV viral particles. This guide connects its molecular identity and reagent handling requirements with antiretroviral drug research and biomimetic permeability-modeling limits.
-
DRB Workflows for Transcriptional Elongation
2026-08-14
DRB provides a rapid, reversible way to probe transcriptional elongation alongside stem-cell fate transitions, signaling, and antiviral phenotypes. This workflow connects CDK-dependent RNA regulation with the YTHDF1 phase-separation model while emphasizing dose, timing, and interpretation controls.
-
Nose-to-Brain mRNA-LNP Delivery for CNS Therapy
2026-08-14
This ACS Nano study develops an intranasal, brain-targeting lipid nanoparticle platform that uses surface-charge screening to improve mRNA delivery through olfactory and trigeminal pathways. In a repetitive mild traumatic brain injury model, co-delivery of BDNF and IL-10 mRNAs reduced neuroinflammation and neuronal loss while improving cognition, illustrating a noninvasive strategy for CNS gene therapy.
-
Esflurbiprofen and SERT–nNOS: Fast Antidepressant Action
2026-08-13
The reference study identifies esflurbiprofen as a fast-onset antidepressant candidate by screening for compounds that disrupt the SERT–nNOS complex in the dorsal raphe nucleus. Its combined interaction assay, stress-model, behavioral, imaging, and mechanistic data support a circuit-level strategy for relieving serotonergic autoreceptor feedback, while also defining important limits for translation beyond mice.
-
Bergenin Targets γδT17 Cells in Psoriasis
2026-08-13
A 2026 Phytomedicine study identifies a previously underappreciated PPARγ–PROX1 pathway through which bergenin suppresses pathogenic γδT17 cells and IL-17A production in psoriasis models. Its combination of immune-cell profiling, metabolic analysis, ubiquitination studies, and chromatin assays links PPARγ activation to CPT1-dependent fatty acid oxidation and inflammatory transcription.